Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.BioImagene, a provider of digital pathology solutions for cancer diagnosis and preclinical research, has closed a $26 million series D financing round led by Burrill & Company.
Subscribe to our email newsletter
Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.
Mohan Uttarwar, CEO of BioImagene, said: “This latest infusion of capital from leading investors is a strong vote of confidence in our team, products and strategy. Our goal is to become the dominant player in this space by 2010.
“We are within range of our target and this funding will help us scale operations to support the rapidly increasing demand for affordable, integrated digital pathology systems.”